Teriparatide (PTH 1-34) studies: 484 papers with results
Page 2 of 10
- A crossover comparison of patient satisfaction with two teriparatide regimens: primary results of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06).
Soen S · Journal of bone and mineral metabolism · 2024
Randomized controlled trial · 7 results
- Randomized crossover comparison of two teriparatide self-injection regimens for primary osteoporosis: Interim report (end of 52-week treatment) of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06).
Soen S · Journal of bone and mineral metabolism · 2025
Randomized controlled trial · 10 results
- Changes in vitamin D metabolites during teriparatide treatment.
Cosman F · Bone · 2012
Randomized controlled trial · 6 results
- Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.
Fujita T · Calcified tissue international · 2014
Randomized controlled trial · 4 results
- Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).
Eastell R · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2009
Randomized controlled trial · 3 results
- Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide.
Takeuchi Y · Calcified tissue international · 2016
Randomized controlled trial · 6 results
- Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
Ste-Marie LG · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2006
Randomized controlled trial · 12 results
- Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide.
Tanaka S · Current medical research and opinion · 2014
Randomized controlled trial · 6 results
- Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels.
Fujita T · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1999
Randomized controlled trial · 18 results
- The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk.
Sone T · Bone · 2014
Randomized controlled trial · 8 results
- PINP as an aid for monitoring patients treated with teriparatide.
Tsujimoto M · Bone · 2011
Randomized controlled trial · 7 results
- A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Zhang XZ · Chinese medical journal · 2009
Randomized controlled trial · 9 results
- [A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China].
Zhang XZ · Zhonghua nei ke za zhi · 2010
Randomized controlled trial · 11 results
- Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.
Yamamoto T · Clinical interventions in aging · 2015
Randomized controlled trial · 6 results
- Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study.
Miyauchi A · Journal of bone and mineral metabolism · 2008
Randomized controlled trial · 11 results
- A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.
Body JJ · The Journal of clinical endocrinology and metabolism · 2002
Randomized controlled trial · 8 results
- Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.
Miller PD · The Journal of rheumatology · 2005
Randomized controlled trial · 5 results
- A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study.
Kung AW · Current medical research and opinion · 2006
Randomized controlled trial · 20 results
- Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis.
Zanchetta JR · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2003
Randomized controlled trial · 16 results
- Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12.
Ikeda S · Journal of bone and mineral metabolism · 2020
Randomized controlled trial · 7 results
- Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.
Farahmand P · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
Randomized controlled trial · 4 results
- Effectiveness of Weekly Teriparatide Injection in Postmenopausal Patients with Hip Fractures.
Lee SY · Clinics in orthopedic surgery · 2023
Randomized controlled trial · 4 results
- Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate.
Cosman F · The Journal of clinical endocrinology and metabolism · 2015
Randomized controlled trial · 34 results
- Effect of Teriparatide Versus Zoledronate on Posterior Lumbar Interbody Fusion in Postmenopausal Women with Osteoporosis.
Xiong Y · World neurosurgery · 2022
Randomized controlled trial · 7 results
- Efficacy of Recombinant Human Parathyroid Hormone 1-34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis.
Zhang Z · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2025
Randomized controlled trial · 8 results
- Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.
Hu S · Clinical pharmacology in drug development · 2024
Randomized controlled trial · 6 results
- Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Ramchand SK · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
Randomized controlled trial · 10 results
- Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
Deal C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005
Randomized controlled trial · 16 results
- The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT.
Ito M · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
Randomized controlled trial · 5 results
- Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis.
Hwang JS · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2006
Randomized controlled trial · 10 results
- Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
Ramchand SK · The Journal of clinical endocrinology and metabolism · 2020
Randomized controlled trial · 6 results
- Differential Effects of Teriparatide and Zoledronic Acid on Bone Mineralization Density Distribution at 6 and 24 Months in the SHOTZ Study.
Dempster DW · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016
Randomized controlled trial · 8 results
- Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study.
Dempster DW · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
Randomized controlled trial · 11 results
- Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
Saag KG · Arthritis & rheumatology (Hoboken, N.J.) · 2016
Randomized controlled trial · 2 results
- Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study.
Takahashi R · Bone · 2024
Randomized controlled trial · 16 results
- Time-dependent changes in skeletal response to teriparatide: escalating vs. constant dose teriparatide (PTH 1-34) in osteoporotic women.
Yu EW · Bone · 2011
Randomized controlled trial · 5 results
- Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.
Wermers RA · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2008
Randomized controlled trial · 5 results
- Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
Michalska D · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
Randomized controlled trial · 6 results
- Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
Zhao Y · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
Randomized controlled trial · 9 results
- Femoral strength in osteoporotic women treated with teriparatide or alendronate.
Keaveny TM · Bone · 2012
Randomized controlled trial · 10 results
- Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women.
Suzuki T · Modern rheumatology · 2019
Randomized controlled trial · 8 results
- Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty.
Tseng YY · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
Randomized controlled trial · 4 results
- Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial.
Anastasilakis AD · International journal of clinical practice · 2008
Randomized controlled trial · 6 results
- The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate.
Shigenobu K · Bone reports · 2019
Randomized controlled trial · 8 results
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human parathyroid hormone (1-34) in healthy Chinese subjects.
Liu Y · Clinical therapeutics · 2014
Randomized controlled trial · 14 results
- PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures. A randomized, controlled study of 40 patients.
Johansson T · Acta orthopaedica · 2016
Randomized controlled trial · 4 results
- Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial.
Paschalis EP · The Journal of clinical endocrinology and metabolism · 2005
Randomized controlled trial · 3 results
- Loading modality and age influence teriparatide-induced bone formation in the human femoral neck.
Rooney AM · Bone · 2020
Randomized controlled trial · 8 results
- Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial.
Nieves JW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
Randomized controlled trial · 5 results
- Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
Tsai JN · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
Randomized controlled trial · 21 results